Lv2
130 积分 2026-02-05 加入
A new regulatory axis in cross-presentation: MS4A7 licenses cDC1s for effective CD8+ T-cell priming
2天前
已完结
Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment
2个月前
已完结
The tetraspan MS4A family in homeostasis, immunity, and disease
3个月前
已完结
Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity
3个月前
已完结
Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity
3个月前
已完结
Approaches for development of LAG-3 inhibitors and the promise they hold as anticancer agents
3个月前
已完结
Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist Antibodies
4个月前
已完结
Upregulated TIGIT+ and Helios+ regulatory T cell levels in bronchoalveolar lavage fluid of NSCLC patients
4个月前
已完结
皖公网安备34019202002308
